According to the 2 industry analysts covering Ensysce Biosciences, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2025, before generating positive ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

While it's next to impossible to know how many opioids entered the state illegally in 2023, we do know that just under 1.7 ...

Online pharmacies will need a proper consultation, not just a patient's questionnaire, to prescribe jabs such as Mounjaro ...

Minnesota Senator Amy Klobuchar is urging the Trump administration to continue negotiating lower prescription drug prices for ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

You can find discounts on a variety of prescription drugs by searching GoodRx, but the ones compiled on the 30 under $30 ...

A 40-year-old man was arrested Saturday for suspicion of felony domestic battery resulting in substantial bodily harm, ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

A Jan. 30 traffic stop led to an undercover drug investigation that resulted in the seizure of over two pounds of fentanyl ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...